Intraosseous hemangiomatosis: technetium-99m(V)dimercaptosuccinic acid and technetium-99m-hydroxymethylene diphosphonate imaging.
We report a case of histologically proven intraosseous hemangiomatosis in which marked accumulation of pentavalent technetium-99m-dimercaptosuccinic acid (99mTc(V)DMSA) and technetium-99m-hydroxymethylene diphosphonate (99mTc-HMDP) was observed in the osteolytic hemangiomatous lesions.
Kobayashi
H
H
Department of Radiology and Nuclear Medicine, Kyoto University, Faculty of Medicine, Japan.
Shigeno
C
C
Sakahara
H
H
Hosono
M
M
Hosono
M
M
Yao
Z S
ZS
Endo
K
K
Konishi
J
J
D000328:Adult; D001859:Bone Neoplasms / Q000000981:diagnostic imaging; D006391:Hemangioma / Q000000981:diagnostic imaging; D006801:Humans; D008297:Male; D015609:Organotechnetium Compounds; D010015:Osteolysis, Essential / Q000000981:diagnostic imaging*; D011877:Radionuclide Imaging; D004113:Succimer; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; D013669:Technetium Tc 99m Medronate / Q000031:analogs & derivatives*
D015609:Organotechnetium Compounds; D019783:Technetium Tc 99m Dimercaptosuccinic Acid; C024226:technetium Tc 99m hydroxymethylene diphosphonate; D004113:Succimer; D013669:Technetium Tc 99m Medronate